ZA200006577B - Phthalazine derivatives as phosphodiesterase 4 inhibitors. - Google Patents
Phthalazine derivatives as phosphodiesterase 4 inhibitors.Info
- Publication number
- ZA200006577B ZA200006577B ZA200006577A ZA200006577A ZA200006577B ZA 200006577 B ZA200006577 B ZA 200006577B ZA 200006577 A ZA200006577 A ZA 200006577A ZA 200006577 A ZA200006577 A ZA 200006577A ZA 200006577 B ZA200006577 B ZA 200006577B
- Authority
- ZA
- South Africa
- Prior art keywords
- phosphodiesterase
- inhibitors
- phthalazine derivatives
- phthalazine
- derivatives
- Prior art date
Links
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 title 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical class C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98MI001671A ITMI981671A1 (it) | 1998-07-21 | 1998-07-21 | Derivati ftalazinici inibitori della fosfodisterasi 4 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200006577B true ZA200006577B (en) | 2002-04-24 |
Family
ID=11380475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200006577A ZA200006577B (en) | 1998-07-21 | 2000-11-13 | Phthalazine derivatives as phosphodiesterase 4 inhibitors. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6340684B1 (xx) |
| EP (1) | EP1098886A1 (xx) |
| JP (1) | JP2002521371A (xx) |
| AU (1) | AU766076B2 (xx) |
| CA (1) | CA2337954A1 (xx) |
| CZ (1) | CZ2001240A3 (xx) |
| EA (1) | EA003702B1 (xx) |
| HU (1) | HUP0103349A3 (xx) |
| IL (1) | IL139491A0 (xx) |
| IT (1) | ITMI981671A1 (xx) |
| NZ (1) | NZ507930A (xx) |
| WO (1) | WO2000005219A1 (xx) |
| ZA (1) | ZA200006577B (xx) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1296984B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| ITMI981671A1 (it) | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodisterasi 4 |
| DE19921567A1 (de) * | 1999-05-11 | 2000-11-16 | Basf Ag | Verwendung von Phthalazine-Derivaten |
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| DE19963607B4 (de) * | 1999-12-23 | 2005-12-15 | Schering Ag | Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen |
| ITMI20000261A1 (it) * | 2000-02-16 | 2001-08-16 | Zambon Group | Processo per la preparazione di piridiniliden-ftalidi |
| US7151102B2 (en) | 2000-10-30 | 2006-12-19 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
| ES2357057T3 (es) | 2002-04-30 | 2011-04-15 | Kudos Pharmaceuticals Limited | Derivados de ftalazinona. |
| US7449464B2 (en) | 2003-03-12 | 2008-11-11 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
| GB0305681D0 (en) | 2003-03-12 | 2003-04-16 | Kudos Pharm Ltd | Phthalazinone derivatives |
| CA2564996A1 (en) * | 2004-05-08 | 2006-01-12 | Taeyoung Yoon | 3-aryl-5,6-disubstituted pyridazines |
| ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
| GB0419072D0 (en) | 2004-08-26 | 2004-09-29 | Kudos Pharm Ltd | Phthalazinone derivatives |
| US20060160814A1 (en) * | 2004-09-03 | 2006-07-20 | Arrington Mark P | Phosphodiesterase 10 inhibitors |
| AR050948A1 (es) | 2004-09-24 | 2006-12-06 | Hoffmann La Roche | Derivados de ftalazinona; su obtencion y su utilizacion en la fabricacion de medicamentos para el tratamiento del cancer. |
| GB0428111D0 (en) * | 2004-12-22 | 2005-01-26 | Kudos Pharm Ltd | Pthalazinone derivatives |
| EP1928437A2 (en) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| GB0521373D0 (en) | 2005-10-20 | 2005-11-30 | Kudos Pharm Ltd | Pthalazinone derivatives |
| JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス，インコーポレイティド | Ｐｄｅ阻害による神経新生の調節 |
| WO2007053596A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| JP2009528365A (ja) * | 2006-02-28 | 2009-08-06 | アムゲン インコーポレイティッド | ホスホジエステラーゼ１０阻害剤としてのシンノリン及びキナゾリン誘導体 |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| EP2026813A2 (en) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| EP2035380A2 (en) * | 2006-06-15 | 2009-03-18 | Kudos Pharmaceuticals Limited | Parp inhibitors |
| CN101484421A (zh) * | 2006-06-15 | 2009-07-15 | 库多斯药物有限公司 | 作为parp抑制剂的2-氧基苯甲酰胺衍生物 |
| WO2007144637A1 (en) * | 2006-06-15 | 2007-12-21 | Kudos Pharmaceuticals Limited | 2 -oxyheteroarylamide derivatives as parp inhibitors |
| WO2008030651A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20080280910A1 (en) * | 2007-03-22 | 2008-11-13 | Keith Allan Menear | Phthalazinone derivatives |
| TW200900396A (en) * | 2007-04-10 | 2009-01-01 | Kudos Pharm Ltd | Phthalazinone derivatives |
| US20090023727A1 (en) * | 2007-07-05 | 2009-01-22 | Muhammad Hashim Javaid | Phthalazinone derivatives |
| WO2009034326A1 (en) | 2007-09-14 | 2009-03-19 | Astrazeneca Ab | Phthalazinone derivatives |
| KR101598231B1 (ko) * | 2007-10-17 | 2016-02-26 | 쿠도스 파마슈티칼스 리미티드 | 4-[3-(4-시클로프로판카르보닐-피페라진-1-카르보닐)-4-플루오로-벤질]-2ｈ-프탈라진-1-온 |
| UY31603A1 (es) | 2008-01-23 | 2009-08-31 | Derivados de ftalazinona | |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| DK2346495T4 (da) | 2008-10-07 | 2023-08-28 | Kudos Pharm Ltd | Farmaceutisk formulering 514 |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| UY32790A (es) * | 2009-07-15 | 2011-02-28 | Astrazeneca Ab | Compuesto de ftalazinona |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| AU2014243818B2 (en) | 2013-03-13 | 2017-04-20 | Flatley Discovery Lab, Llc | Pyridazinone compounds and methods for the treatment of cystic fibrosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3274185A (en) * | 1963-10-08 | 1966-09-20 | S E Massengill Company | Phthalazine derivatives |
| GB2063249A (en) | 1979-10-09 | 1981-06-03 | Mitsubishi Yuka Pharma | 4-Phenylphthalazine derivatives |
| US6207666B1 (en) * | 1995-06-07 | 2001-03-27 | Cell Pathways, Inc. | Method for treating a patient having precancerous lesion with 4-phenylphthalazine derivatives |
| JP2001506653A (ja) | 1996-12-18 | 2001-05-22 | ニューロゲン コーポレイション | Ｃｒｆレセプターと相互作用するイソキノリナミン及びフタルアジナミン誘導体 |
| IT1296985B1 (it) | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
| IT1296984B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| ITMI981670A1 (it) | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| ITMI981671A1 (it) | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodisterasi 4 |
-
1998
- 1998-07-21 IT IT98MI001671A patent/ITMI981671A1/it unknown
-
1999
- 1999-07-16 HU HU0103349A patent/HUP0103349A3/hu unknown
- 1999-07-16 NZ NZ507930A patent/NZ507930A/xx unknown
- 1999-07-16 US US09/764,983 patent/US6340684B1/en not_active Expired - Fee Related
- 1999-07-16 IL IL13949199A patent/IL139491A0/xx unknown
- 1999-07-16 EA EA200100061A patent/EA003702B1/ru not_active IP Right Cessation
- 1999-07-16 CZ CZ2001240A patent/CZ2001240A3/cs unknown
- 1999-07-16 WO PCT/EP1999/005068 patent/WO2000005219A1/en not_active Ceased
- 1999-07-16 EP EP99932894A patent/EP1098886A1/en not_active Withdrawn
- 1999-07-16 CA CA002337954A patent/CA2337954A1/en not_active Abandoned
- 1999-07-16 JP JP2000561175A patent/JP2002521371A/ja active Pending
- 1999-07-16 AU AU49116/99A patent/AU766076B2/en not_active Ceased
-
2000
- 2000-11-13 ZA ZA200006577A patent/ZA200006577B/xx unknown
-
2001
- 2001-11-14 US US09/987,266 patent/US6498160B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2337954A1 (en) | 2000-02-03 |
| JP2002521371A (ja) | 2002-07-16 |
| EP1098886A1 (en) | 2001-05-16 |
| ITMI981671A1 (it) | 2000-01-21 |
| ITMI981671A0 (it) | 1998-07-21 |
| EA003702B1 (ru) | 2003-08-28 |
| WO2000005219A1 (en) | 2000-02-03 |
| CZ2001240A3 (cs) | 2001-09-12 |
| NZ507930A (en) | 2002-11-26 |
| EA200100061A1 (ru) | 2001-08-27 |
| AU4911699A (en) | 2000-02-14 |
| IL139491A0 (en) | 2001-11-25 |
| AU766076B2 (en) | 2003-10-09 |
| US20020058662A1 (en) | 2002-05-16 |
| US6498160B2 (en) | 2002-12-24 |
| HUP0103349A2 (hu) | 2002-02-28 |
| US6340684B1 (en) | 2002-01-22 |
| HUP0103349A3 (en) | 2003-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200006577B (en) | Phthalazine derivatives as phosphodiesterase 4 inhibitors. | |
| IL141445A0 (en) | Benzazine derivatives as phosphodiesterase 4 inhibitors | |
| EG24743A (en) | Heterocyclic compounds. | |
| ZA99254B (en) | Benzosulfone derivatives. | |
| PL349504A1 (en) | 1,2-annelated quinoline derivatives | |
| ZA200007593B (en) | Quinoline Derivatives. | |
| ZA977695B (en) | 1,4-heterocyclic metalloprotease inhibitors. | |
| ZA977693B (en) | 1,3-diheterocyclic metalloprotease inhibitors. | |
| ZA986905B (en) | Substituted quinazoline derivatives. | |
| PL345540A1 (en) | Thiobenzimidazole derivatives | |
| IL139490A0 (en) | Phthalazine derivatives as phosphodiesterase 4 inhibitors | |
| GB9809664D0 (en) | a-Ketoamide derivatives | |
| AU2274299A (en) | Benzazine derivatives phosphodiesterase 4 inhibitors | |
| GB2343574B (en) | Sense amplifier | |
| AU5652698A (en) | (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors | |
| ZA99873B (en) | Novel dihydroxyhexanoic acid derivatives. | |
| IL141446A0 (en) | Benzazine derivatives as phosphodiesterase 4 inhibitors | |
| AU3706399A (en) | Phosphodiesterase iv-inhibiting diazepinoindoles | |
| PL342060A1 (en) | Derivatives of 1,3,4-oxadiaxolone | |
| ZA991550B (en) | Cyclohexanediole derivatives. | |
| EG23802A (en) | 2-Phenylpyran-4-one derivatives | |
| ZA974953B (en) | Substituted pyrazolylpyrazole derivatives. | |
| ZA982436B (en) | Thiazolimine derivatives. | |
| ZA986095B (en) | 6-azauracil derivatives as IL-5 inhibitors. | |
| IL143530A0 (en) | Pyridazinone derivatives |